2024. Transcription factor ASCL1 targets SLC6A13 to inhibit the progression of hepatocellular carcinoma via the glycine-inflammasome signaling. Biomolecules and Biomedicine. (May 2024). DOI:https://doi.org/10.17305/bb.2024.10328.